Skip to main content

Otero Jose Manuel's Form 4/A amendment

Amended

Lexeo Therapeutics, Inc.LXEO · filed Feb 20, 2026

Accession no.
0002024096-26-000004
Filed
Feb 20, 2026
Trade date
Nov 18, 2025
Filing delay
94 days
Rule 10b5-1 plan
Not checked
Original filed
Nov 20, 2025

This filing lists 1 non-derivative transaction. Open-market sales total $6.68K. It was filed 94 days after the trade.

This amendment replaces 0002024096-25-000005 (filed Nov 20, 2025).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Otero Jose ManuelCIK 0002024096Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 18, 2025Common StockSSaleDisposed−721$9.27F3−$6,683.6763,476Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On November 20, 2025, the reporting person filed a Form 4 which inadvertently reported that a sale to cover tax obligations occurred on August 18, 2025. In fact, as reported in this amendment, the sale occurred on November 18, 2025.

F2

Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

F3

This transaction was executed in multiple trades at prices ranging from $9.09 to $9.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

F4

Includes 47,733 RSUs.

Read the full filing on SEC EDGAR (opens in a new tab)